US Business
U.S. Health Officials Raise Concerns Over AstraZeneca Data
U.S. officials said they had been told AstraZeneca may have released outdated information in its disclosure of trial results for its Covid-19 vaccine, which could have “provided an incomplete view of the efficacy data.”
